• Children’s Cancer Foundation (CCF) partners the SingHealth Duke-NUS  Paediatrics Academic Clinical Programme (ACP) to establish the Tan Cheng Lim – CCF Professorship in Paediatric Oncology
  • Professorship is named in honour of one of Singapore’s pioneers in paediatric oncology
KK Women’s and Childrens Hospital (KKH) sees more than 100 cases of childhood cancer each year.   With advances in the understanding of cancer biology, drug therapy and state-of-the-art therapies, many of these kids survive into adulthood.
 
To further push the frontiers of clinical research in paediatric oncology in Singapore and enhance future treatment and care for children affected by cancers, Children’s Cancer Foundation (CCF) partnered the SingHealth Duke-NUS Paediatrics Academic Clinical Programme (ACP) to establish the Tan Cheng Lim – CCF Professorship in Paediatric Oncology.
 
Once appointed, the recipient of this Professorship will play a role in advancing research, education, and clinical management of children with cancer.
 
The Professorship is named in honour of Emeritus Consultant, Professor Tan Cheng Lim, one of Singapore’s pioneers in paediatric oncology.
 
Prof Tan, a devoted clinician-mentor and educator, is the longest-serving paediatrician in public healthcare with a career spanning five decades.   This Professorship builds upon Prof Tan’s legacy and pioneering contributions in advancing paediatric medicine.
 
“This partnership will enhance the medical well-being of our children as they stand to benefit from the clinical research aimed at improving diagnosis, treatment and cure of childhood cancer,” said Mr Ho Cheng Huat, Chairperson of CCF.
 
Associate Professor Ng Kee Chong, Academic Chair for the SingHealth Duke-NUS Paediatrics ACP and Chairman, Division of Medicine, KKH, added,
 
“The impact will undoubtedly touch the lives of many and bring much hope to our young patients and their families.”
 
The endowed Professorship was made possible through a $2.5 million contribution from CCF and with a dollar-for-dollar matching by the Singapore government, the fund for children’s cancer research is doubled to $5 million.